Background Autoantibodies against the 81-adrenoceptor have been detected in the sera of patients with idiopathic dilated cardiomyopathy (DCM). The mechanisms by which these autoantibodies can alter normal receptor function are investigated, and the results are interpreted in the light of the beneficial effects of P1-blockade in some of these patients. Methods and Results Autoantibodies against the 31-adrenoceptor, affinity purified from sera of patients with idiopathic DCM, were analyzed in a functional test system of spontaneously beating neonatal rat heart myocytes. Antibodies from rabbits immunized with peptides derived from the amino acid sequence of this receptor were also analyzed. Autoantibodies against the second extracellular loop increased the beating frequency of isolated myocytes in a concentration-dependent manner, to approximately 80% of maximal isoproterenol stimulation. Rabbit anti-peptide antibodies against the second extracellular loop increased the beating frequency correspondingly. Autoantibodies and rabbit anti-peptide antibodies against the second extracellular loop were able to immunoprecipitate the unliganded receptor but not the antagonist-occupied receptor. In contrast, rabbit antibodies against the extracellular N-terminal sequence 34-57 of the p1-adrenoceptor were able to immunoprecipitate both the unliganded and the antagonist-occupied receptor although with no effect on the beating frequency of myocytes. The positive chronotropic effect of the antibodies was completely neutralized both by the addition of increasing concentrations of the P1-selective antagonist bisoprolol and by preincubation with the peptide corresponding to the second extracellular loop. The antibodyinduced increase in beating frequency remained unchanged for more than 6 hours. This should be compared with the isoproterenol-stimulated beating frequency, which undergoes desensitization within 60 minutes. Addition of isoproterenol to autoantibody-stimulated myocytes resulted in only a small increase in beating frequency and did not cause desensitization. Antibodies had only a marginal effect on cyclic AMP production of stimulated cardiomyocytes compared with the 10-fold increase obtained after stimulation with isoproterenol.
Conclusions The second extracellular loop of the tB1-adrenoceptor is a specific target for antibodies with stimulatory activity detected in patients with idiopathic DCM. The antibodies have a positive chronotropic effect on isolated rat heart myocytes. Autoantibody stimulation does not cause the normal agonist-induced desensitization phenomena of the effector system. These findings could contribute to our understanding of the pathophysiological mechanisms of the autoantibodies and of the beneficial effect of P,-blocking agents in The purpose of the present study was to see whether the epitopic target of the autoantibodies, which have a positive chronotropic effect, could be identified as the second extracellular loop. Autoantibodies from patients with idiopathic DCM were affinity purified on a peptide corresponding to the sequence of this loop. Concomitantly, rabbit antibodies were induced against the same peptide and tested for their potential to mimic the human autoantibodies by comparing their immunochemical properties, their pharmacological specificities, and their functional activities on cardiomyocytes in vitro.
Methods

Patients
All patients (six men and one woman; age, 55±9 years) had been clinically diagnosed as having idiopathic DCM. They all had been hospitalized for congestive heart failure and were treated with diuretics, digitalis, and angiotensin-converting enzyme inhibitors. None of the patients were receiving treatment with ,8-blockers, calcium blockers, or inotropic or antidepressant drugs. Coronary artery disease was excluded based on coronary angiography, and no patient had a history of hypertension, valvular heart disease, diabetes, or any other endocrinal disorder or suspicion of alcohol or drug abuse. Acute or chronic myocarditis was excluded by the findings of right ventricular endomyocardial biopsy. All patients had signs of depressed left ventricular function (ejection fraction, 25 ±9%) as judged from noninvasive investigation by M-mode and two-dimensional echocardiography. The New York Heart Association functional class of the patients was 2.5+±0.5.
Peptides
Two peptides, corresponding to the sequence of the extra- and of the second extracellular loop (197- 
Affinity Purification of Antibodies
Based on a sera-positive response in an enzyme immunoassay to peptide 197-222 of the P,-adrenoceptor, sera from four patients with DCM were selected, pooled, and affinity purified (pool n=4). Positive sera from three additional patients with DCM were individually affinity purified (patients 5 through 7). The sera of immunized rabbits, described in the previous section, were also affinity purified. All sera were affinity purified in the following manner: the affinity column was made up by coupling the peptide 197-222 or the peptide 34- 
Statistical Analysis
The increase in beating frequency compared with the corresponding control period before addition of antibody or isoproterenol was analyzed using Student's paired t test. The data are given as mean +±SEM. The immunoprecipitation data were analyzed with Student's unpaired t test. A probability level of P<.05 was chosen as the least significant difference.
Results
Immunological Characterization of the Antibodies
Affinity-purified antibodies from patients with idiopathic DCM and from immunized rabbits were tested for the recognition of peptide sequence 197-222 corresponding to the second extracellular loop of the human ,81-adrenoceptor using an enzyme immunoassay. As shown in Fig 1, onist-receptor complex, confirming the adequacy of the test (Fig 2) . All antibodies were able to immunoprecipitate the unliganded receptor, as shown by the decrease of ligand-binding sites in the supernatants of solubilized receptor after immunoprecipitation (Fig 3) . 
Functional Characterization of the Antibodies
The Table summarizes the chronotropic effect of autoantibodies from patients with idiopathic DCM and anti-peptide antibodies from immunized rabbits on cultured rat heart myocytes. Affinity-purified autoantibodies from pooled sera of four patients increased the beating frequency of cultured rat heart myocytes with a mean maximum of 32.4+4.9 beats per minute (P<.001). Individually purified autoantibodies from patients 5 through 7 increased the beating frequency to the same extent with mean maxima of 33 (Fig 4) .
Furthermore, preincubation of both the autoantibodies and the anti-peptide antibodies with the antigenic peptide 197-222 at 25 nmol/L for 1 hour resulted in the antibodies no longer being able to induce stimulation. This confirms that the antibody effect is attributable to interaction of the antibody combining site with its target epitope on the myocytes and not to nonspecific effects induced by recognition of the antibody Fc fragment. In these studies, each experiment was followed by addition of isoproterenol at 10 ,umol/L to confirm that the myocytes responded properly ( Table) .
To determine that only recognition of the second extracellular loop was responsible for the positive chronotropic effect induced by the antibodies, rabbit antibodies were induced and affinity purified against the extracellular N-terminal sequence 34- 82.9+10.3 to 1648+12.3 pmol/mg protein), the antibodies had only a marginal although significant effect (from 139.5±8.6 to 167.5±7.6 pmol/mg protein). The cAMP accumulation in the presence of antibody and isoproterenol together was 1054±10.0 pmol/mg.
Concentration Dependency of the Functional Antibodies
The positive chronotropic effect of the autoantibodies from patients with idiopathic DCM was concentration dependent (Fig 5) . This stimulation was significant at 0.02 nmol/L (P<.01) with a mean maximum at 0. (Fig 1) with the concentration-response curve of the functional assay, it can be seen that autoantibodies of cardiomyopathic patients behave similarly in both assays with respect to their concentration, whereas the anti-peptide antibodies from rabbits are able to recognize the peptide with an apparent affinity 1000 times higher than the concentration at which they are able to induce the positive chronotropic effect (Fig 5) . Time Dependency of the Functional Antibodies
In Fig 6 , the stimulatory effect of the autoantibodies from patients with idiopathic DCM and anti-peptide antibodies of rabbit (197-222)-1 was investigated as a function of time. In sharp contrast to the chronotropic action of isoproterenol, which was subject to relatively rapid desensitization, the action of the antibodies was maintained at approximately peak levels for more than 6 hours. This action was not even reversed by washing and subsequent incubation for a few hours in fresh culture medium without the antibodies. The positive chronotropic effect was, however, completely and rapidly reversed by treatment with the 8,1-selective blocking agent bisoprolol at 1 ,umol/L. When the agonist isoproterenol was added to autoantibody-stimulated myocytes, only a small increase in beating frequency was observed, and this increase was lower than that induced by the agonist alone. Moreover, in the presence of autoantibodies, the desensitization phenomenon normally induced by the agonist did not occur. When the autoantibodies and the agonist were washed out after the addition of 1 ,umol/L bisoprolol, the cardiomyocytes responded to a new stimulation with isoproterenol as they did to a first stimulation. In contrast, isoproterenol restimulation of agonist-desensitized cells did not result in a significant increase in beating frequency (Fig 7) .
Discussion
It has recently been suggested that autoantibodies against the ,B-adrenoceptor were present in sera of patients with idiopathic DCM.8-'2 Similar results were obtained by our group using a different experimental approach to characterize autoantibodies. It was found that in about 30% of patients with idiopathic DCM, autoantibodies against the predicted second extracellular loop of the ,31-adrenergic receptor were present.9
Because the second extracellular loop was found to be immunogenic in rabbits, this structure was investigated. 21 This loop contains cysteine residues, which have been shown to interact with agonist binding and receptor activation.2223 The autoantibodies from idiopathic DCM patients9 as well as the rabbit antibodies induced by immunization with a peptide corresponding to the sequence of the loop were able to inhibit radioligand binding on the receptor. This inhibition appeared to reflect a labile "activated" state of the receptor. 24 On the other hand, it was found that the y-globulin fraction of patients with DCM was able to induce a positive chronotropic effect on neonatal rat heart myocytes in culture.1011 Thus, an effort was made to answer the question of whether the antibodies directed against the second extracellular loop of the human 81-adrenoceptor are identical to those that can induce a positive chronotropic effect. The immunological and functional data presented in this study give an unequivocally positive answer to that question.
The affinity-purified autoantibodies from patients with idiopathic DCM were stimulatory in the functional assay. Because the major part of the y-globulin fraction, which was not adsorbed on the peptide immunosorbent, lacked any stimulatory effect, it was concluded that the stimulatory activity was attributable only to the recognition of the second extracellular loop of the receptor. A similar concentration dependency (0.02 to 0.41 nmol/L) was found both for epitopic recognition in an enzyme immunoassay and for the functional effect of the autoantibodies (Figs 1 and 5) . These results contrast sharply with the action of affinity-purified rabbit anti-peptide (197-222) antibodies, which were able to recognize the peptide with an apparent affinity 1000 times higher than the concentration in which they were able to induce the positive chronotropic effect. This discrepancy can be explained by the fact that the antibody response in the patients is oligoclonal and directed completely toward the epitope on the peptide that is responsible for the physiological effect on the receptor, whereas the antibodies from the immunized rabbits are polyclonal in nature and directed against all the epitopes present on the second extracellular loop, with only a minor fraction directed at the epitope responsible for the physiological effect. It is even possible that the antibodies directed toward the nonfunctional epitopes may block the accessibility of the functional antibodies to their epitopic target through steric hindrance. This suggests the prevalence of protective antibodies over functional antibodies in the peptide (197-222)-induced immune response.
The epitope specificity of the stimulatory activity by the antibodies was further assessed by studying rabbit antibodies against an immunogenic region of the extracellular N-terminal sequence 34-57 of the human /1-adrenoceptor. These antibodies were able to immunoprecipitate the antagonist-receptor complex but were unable to increase the beating frequency of spontaneously beating rat heart myocytes in culture. In contrast, the antibodies against the second extracellular loop did not precipitate the antagonist-receptor complex but only the unliganded receptor. Thus, the functional effect of the autoantibodies is not attributable to the activation of the receptor by cross-linking with antireceptor antibodies as is the case for immunological receptors26 or growth hormone receptors,27 but rather is caused by the interaction of the antibodies with a functional important epitope, which is not accessible on the antagonist-receptor complex.
Although The nondesensitization observed with the autoantibodies appears to be in apparent contradiction with receptor downregulation observed in failing hearts. The observations made in vitro, however, are quite different from the situation in vivo, in which all complementary immune components (eg, complement, cytotoxic cells, phagocytes) are present to induce immune endocytosis of the receptor. In the absence of any data linking directly the in vitro model to the in vivo model and in the absence of a mechanistic interpretation of the effect of the autoantibodies, no direct pathophysiological interpretation can be given to the observation presented here. We can, however, present a testable hypothesis. If the antibody-receptor complexes remain at the plasma membrane, the opportunity of immune downregulation can only increase. If, on the other hand, the /3-blockers dissociate the antigen-antibody complex, they at the same time inhibit immune downregulation of the receptor and its target cell. The therapeutic efficacy of /31-selective /3-blockers in some patients with DCM may be partly explained by their ability to dissociate the /3-adrenoceptor-antibody complex and to block continuous adrenergic overstimulation. Therefore, we might expect a more favorable response to long-term 83-blockade in patients with circulating anti-receptor autoantibodies than in patients without such antibodies. A clinical study aimed at analyzing whether a correlation exists between the beneficial effects of /1-selective blocking agents and the presence of autoantibodies against the /,3-adrenoceptor in patients with idiopathic DCM is in progress. If this correlation exists, the hypothesis forwarded here should be strengthened.
